BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Rapamycin
,
rs2476601
,
TGFB1
,
glucose metabolic process
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
factor- iii
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Estimating the measurement uncertainties of the international sensitivity index of 12 thromboplastin…
Is 10 min post heparin bolus ACT, alongside aPTT monitoring, predictive for CRRT filter survival?
Molecular dynamics simulation and free energy calculation studies of Coagulin L as dipeptidyl peptid…
Thromboplastin calibration revisited to look for possible revision of the World Health Organization …
Effect of the reaction temperature on the prothrombin time and the apparent International Normalized…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Changes of Transforming Growth Factor b1 and Procollagen III in Patients With Acute Respiratory Dist…
Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III
A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa
Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung …
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation F…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ